Boulder Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.
BiotechHealthtechRadnor, US
Eric Warren(Chief Commercial Officer)Alex Gold(Chief Medical Officer)Adam Levy(Executive Officer)Alexander Asam(Director)
BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)Olivier Litzka(Director)in
Co-investorsAndera PartnersSamsara BioCapitalSR One Capital ManagementYsios CapitalCatalys PacificRA Capital
RapidFort provides a software supply chain security platform that analyzes and hardens container images to eliminate vulnerabilities and reduce attack surface across development and production environments.
Cloud ComputingCybersecurityDeveloper ToolsSunnyvale, US
Mehran Farimani(CEO & Founder)inRuss Andersson(COO, Co-founder)inRajeev Thakur(CTO & Founder)inGeorge Manuelian(CRO, Co-founder)inRajeev T(Founder)
BoardRobert Mee(Director)
Co-investorsForgePoint CapitalCheyenne VenturesDelta-v CapitalEvolution VenturesFelicis VenturesFlorida Funders+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.